IGF1 and cholangiocarcinoma: In this study, the genes ALB, MYC, APOB, IGF1 and KNG1 were demonstrated to be involved in CCA, as well as these genes may be used as potential diagnosis biomarkers, treatment targets and prognosis markers for patients with CCA.